We, therefore, hypothesize that oncogenic HH/GLI signaling drives BCC growth by suppressing the antitumoral immune response and possibly, also by recruiting inflammatory cells with tumor‐promoting function. The gene discussed is GLI1; the disease is skin basal cell carcinoma.